This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grellscheid, S.-N. Articles by Smith, C. W. J. Search for Related Content PubMed PubMed Citation Articles by Grellscheid, S.-N. Articles by Smith, C. W. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2006, p. 2237-2246, Vol. 26, No. 6
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.6.2237-2246.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

An Apparent Pseudo-Exon Acts both as an Alternative Exon That Leads to Nonsense-Mediated Decay and as a Zero-Length Exon

Sushma-Nagaraja Grellscheid and Christopher W. J. Smith^*

Department of Biochemistry, University of Cambridge, 80 Tennis Court Rd., Cambridge CB2 1GA, United Kingdom

Received 29 September 2005/ Returned for modification 26 October 2005/ Accepted 21 December 2005

Pseudo-exons are intronic sequences that are flanked by apparent consensus splice sites but that are not observed in spliced mRNAs. Pseudo-exons are often difficult to activate by mutation and have typically been viewed as a conceptual challenge to our understanding of how the spliceosome discriminates between authentic and cryptic splice sites. We have analyzed an apparent pseudo-exon located downstream of mutually exclusive exons 2 and 3 of the rat -tropomyosin (TM) gene. The TM pseudo-exon is conserved among mammals and has a conserved profile of predicted splicing enhancers and silencers that is more typical of a genuine exon than a pseudo-exon. Splicing of the pseudo-exon is fully activated for splicing to exon 3 by a number of simple mutations. Splicing of the pseudo-exon to exon 3 is predicted to lead to nonsense-mediated decay (NMD). In contrast, when "prespliced" to exon 2 it follows a "zero length exon" splicing pathway in which a newly generated 5' splice site at the junction with exon 2 is spliced to exon 4. We propose that a subset of apparent pseudo-exons, as exemplified here, are actually authentic alternative exons whose inclusion leads to NMD.

---

* Corresponding author. Mailing address: Department of Biochemistry, University of Cambridge, 80 Tennis Court Rd., Cambridge CB2 1GA, United Kingdom. Phone: 44-1223-333655. Fax: 44-1223-766002. E-mail: cwjs1{at}cam.ac.uk.

Present address: Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne NE1 3BZ, United Kingdom.

---

Molecular and Cellular Biology, March 2006, p. 2237-2246, Vol. 26, No. 6
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.6.2237-2246.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Pastor, T., Talotti, G., Lewandowska, M. A., Pagani, F. (2009). An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM. Nucleic Acids Res 0: gkp778v1-gkp778 [Abstract] [Full Text]  
• Coles, J. L., Hallegger, M., Smith, C. W.J. (2009). A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F. RNA 15: 33-43 [Abstract] [Full Text]  
• Heier, C. R., Gogliotti, R. G., DiDonato, C. J. (2007). SMN Transcript Stability: Could Modulation of Messenger RNA Degradation Provide a Novel Therapy for Spinal Muscular Atrophy?. J Child Neurol 22: 1013-1018 [Abstract]  
• Buratti, E., Dhir, A., Lewandowska, M. A., Baralle, F. E. (2007). RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. Nucleic Acids Res 35: 4369-4383 [Abstract] [Full Text]  
• Elliott, D. J, Grellscheid, S. N (2006). Alternative RNA splicing regulation in the testis.. Reproduction 132: 811-819 [Abstract] [Full Text]  
• Buratti, E., Baralle, M., Baralle, F. E. (2006). Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 34: 3494-3510 [Abstract] [Full Text]